Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease

Nephrology Dialysis Transplantation

Volumn 23, Issue 12, 2008, Pages 3996-4001

  Kumada, Yoshitaka ^a   Aoyama, Toru ^a,b   Ishii, Hideki ^b   Tanaka, Miho ^a   Kawamura, Yoshihiro ^a   Takahashi, Hiroshi ^a   Toriyama, Takanobu ^a   Yuzawa, Yukio ^b   Maruyama, Syoichi ^b   Matsuo, Seiichi ^b   Murohara, Toyoaki ^b  

^a Nagoya Kyoritsu Hospital   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Haemodialysis; Percutaneous transluminal angioplasty; Peripheral artery disease

Indexed keywords

ADULT; AGED; AMPUTATION; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INCIDENCE; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AMPUTATION; ANGIOPLASTY, BALLOON; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; LEG; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 56749178920     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn378     Document Type: Article

References (22)

1. United States Renal Data System. Annual Data Report. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Division of Kidney, Urologic and Hematologic Disease, 2000, 339-348
2. O'Hare AM, Glidden DV, Fox CS et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the national health and nutrition examination survey 1999-2000. Circulation 2004; 109: 320-323
3. O'Hare AM, Bertenthal D, Shlipak MG et al. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 2005; 16: 514-519
4. O'Hare AM, Feinglass J, Sidawy AN et al. Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of veterans affairs' national surgical quality improvement program. J Am Soc Nephrol 2003; 14: 1287-1295
5. Ramdev P, Rayan SS, Sheahan M et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg 2002; 36: 969-974
6. Korn P, Hoenig SJ, Skillman JJ et al. Is lower extremity revascularization worthwhile in patients with end-stage renal disease? Surgery 2000; 128: 472-479
7. Hakaim AG, Gordon JK, Scott TE. Early outcome of in situ femorotibial reconstruction among patients with diabetes alone versus diabetes and end-stage renal failure: analysis of 83 limbs. J Vasc Surg 1998; 27: 1049-1054
8. O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2838-2847
9. O'Hare AM, Sidawy AN, Feinglass J et al. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg 2004; 39: 709-716
10. Faglia E, Dalla Paola L, Clerici G et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005; 29: 620-627
11. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg 2005; 41: 423-435
12. Tefera G, Hoch J, Turnipseed WD. Limb-salvage angioplasty in vascular surgery practice. J Vasc Surg 2005; 41: 988-993
13. Graziani L, Silvestro A, Bertone V et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant 2007; 22: 1144-1149
14. Jaar BG, Astor BC, Berns JS et al. Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients. Kidney Int 2004; 65: 613-620
15. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45: S5-S67
16. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108: 2154-2169
17. Nakai S, Masakane I, Akiba T et al. Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther Apher Dial 2007; 11: 411-441
18. Held PJ, Brunner F, Odaka M et al. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 1990; 15: 451-457
19. Hase H, Joki N, Nakamura M et al. Favourable long-term outcome by repeated percutaneous coronary revascularization in diabetic haemodialysis patients. Nephrol Dial Transplant 2002; 17: 100-105
20. Aoki J, Ikari Y, Nakajima H et al. Coronary revascularization improves long-term prognosis in diabetic and nondiabetic end-stage renal disease. Circ J 2002; 66: 595-599
21. Yasuda K, Kasuga H, Aoyama T et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 2006; 17: 2322-2332
22. Toriyama T, Kumada Y, Matsubara T et al. Effect of artificial carbon dioxide foot bathing on critical limb ischemia (Fontaine IV) in peripheral arterial disease patients. Int Angiol 2002; 21: 367-373